Clinical Trials Browser

Recruiting × OTHER_GOV × sintilimab × Clear all

NCT06329973 2025-07-17

Fruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer

Phase 1/2 Recruiting

Gastrointestinal

Metastatic Gastroesophageal Junction Adenocarcinoma

NCT05495152 2024-10-02

Adjuvant Sintilimab for Locally Advanced Esophageal Squamous Cell Carcinoma

Phase 3 Recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma